Bacolod MD, Schemmann GS, Wang S, Shattock R, Giardina SF, Zeng Z, Shia J, Stengel RF, Gerry N, Hoh J et al..
2008.
The signatures of autozygosity among patients with colorectal cancer.. Cancer Res. 68(8):2610-21.
Hu X, Herrero C, Li W-P, Antoniv TT, Falck-Pedersen E, Koch AE, Woods JM, G Haines K, Ivashkiv LB.
2002.
Sensitization of IFN-gamma Jak-STAT signaling during macrophage activation.. Nat Immunol. 3(9):859-66.
Ma X.
2018.
Sensing danger through a "finger".. J Exp Med. 215(12):2969-2971.
Zhan W, Hsu H-C, Morgan T, Ouellette T, Burns-Huang K, Hara R, Wright AG, Imaeda T, Okamoto R, Sato K et al..
2019.
Selective Phenylimidazole-Based Inhibitors of the Mycobacterium tuberculosis Proteasome.. J Med Chem. 62(20):9246-9253.
Bryk R, Gold B, Venugopal A, Singh J, Samy R, Pupek K, Cao H, Popescu C, Gurney M, Hotha S et al..
2008.
Selective killing of nonreplicating mycobacteria.. Cell Host Microbe. 3(3):137-45.
Blumenthal A, Kobayashi T, Pierini LM, Banaei N, Ernst JD, Miyake K, Ehrt S.
2009.
RP105 facilitates macrophage activation by Mycobacterium tuberculosis lipoproteins.. Cell Host Microbe. 5(1):35-46.
Yamamoto S, Ma X.
2009.
Role of Nod2 in the development of Crohn's disease.. Microbes Infect. 11(12):912-8.